search
Back to results

Creatine Use and Muscle Stretching in Peripheral Artery Disease

Primary Purpose

Peripheral Arterial Disease

Status
Completed
Phase
Phase 2
Locations
United States
Study Type
Interventional
Intervention
Creatine monohydrate
Cellulose
Sponsored by
Florida State University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Peripheral Arterial Disease focused on measuring Muscle stretch, Creatine Monohydrate

Eligibility Criteria

40 Years - 95 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  1. Ankle-brachial index (ABI) of 0.90 or less in either leg or clinical diagnosis by a medical doctor (PAD group only)
  2. Stable condition for at least 3 months (PAD group only)

Exclusion Criteria:

  1. Habitual exercise or cardiovascular rehabilitation program during the past 3 months
  2. Critical limb ischemia
  3. Blow or above-knee amputation
  4. Leg pain at rest
  5. Major surgery or lower extremity revascularization in the last 3 months
  6. Major medical illness treatment during the prior 12 months
  7. Central neurological disease
  8. Limited ankle or knee joint range of motion
  9. Requirement of oxygen with activity or exercise
  10. Heart failure
  11. Atrial fibrillation
  12. Wheelchair confinement or inability to walk
  13. Cognitive disorder
  14. Vasculitis problems including Takayasu's arteritis, Berger's disease, collagen disease or Reynaud's disease
  15. Overt cardiovascular disease
  16. Metabolic disease
  17. Renal disease

Sites / Locations

  • Florida State University

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

Creatine monohydrate

Cellulose

Arm Description

Creatine Monohydrate will be given at a 5 day loading period (10g/day) followed by a maintenance phase (5 g/day). The objectives of the current trial are to investigate if creatine supplementation plus muscle stretching improves 6-minute walking distance and muscle oxygenation in patients with peripheral artery disease.

These participants will consume a fiber supplement in place of creatine monohydrate at a matched dose with muscle stretching.

Outcomes

Primary Outcome Measures

Walking tolerance
All patients will perform a pre -and -post 6 minute walking test to assess functional outcomes of muscle stretching and supplementation

Secondary Outcome Measures

Near infrared spectroscopy (NIRS)
Use of NIRS on the lateral head of the gastrocnemius muscle in all patients will be performed. NIRS will be measured during a vascular occlusion test, during placement of splint device, and the 6 minute walking test.
Magnetic Resonance Imaging (MRI)
Use of MRI to assess muscle oxygenation during a vascular occlusion test at rest, and during placement of splint device

Full Information

First Posted
June 20, 2020
Last Updated
February 11, 2023
Sponsor
Florida State University
search

1. Study Identification

Unique Protocol Identification Number
NCT04471792
Brief Title
Creatine Use and Muscle Stretching in Peripheral Artery Disease
Official Title
Creatine Monohydrate Use and Muscle Stretching in Peripheral Artery Disease
Study Type
Interventional

2. Study Status

Record Verification Date
February 2023
Overall Recruitment Status
Completed
Study Start Date
May 12, 2020 (Actual)
Primary Completion Date
December 15, 2022 (Actual)
Study Completion Date
December 15, 2022 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Florida State University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
Yes
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
To utilize near-infrared spectroscopy to investigate if the research device, which induces muscle stretching, and creatine loading impact submaximal exercise performance in aged and PAD patients. Near-infrared spectroscopy (NIRS)-derived tissue oxygenation responses will be obtained during device placement (muscle stretch) and during a walking test (i.e., six-minute walk test). Muscle oxygenation at rest and during device placement will be assessed with Magnetic Resonance Imaging. It is hypothesized that the stretching protocol will improve both NIRS-derived tissue oxygenation and magnetic resonance-derived muscle oxygenation and that creatine supplementation will further improve phosphorus metabolite muscle performance. All patients will undergo either 4 weeks of stretch training with- or- without creatine supplementation according to previously defined creatine guidelines.
Detailed Description
Lower extremity peripheral artery disease (PAD) has been estimated to impact nearly 8.5 million U.S. adults above the age of 40, significantly increasing the rate of morbidity and mortality with concomitant decreases in quality of life. These patients are often given medical therapy (e.g., statins, antiplatelet, anticoagulants) and are also recommended to begin structured exercise programs. However, the limb ischemia that occurs during physical activity in these patients often limits exercise tolerance. A previous study by Bauer and colleagues showed that impaired muscle metabolism is a major contributor to functional limitations in PAD patients. These data are important in that they show alterations in blood flow and metabolic machinery likely impact exercise tolerance. As such, the development of tolerable countermeasures to improve limb blood flow and muscle energetics may increase adherence to exercise therapy and improve health outcomes in PAD patients. Previous work by the investigators has shown that daily muscle stretching, achieved via 30-minutes of ankle dorsiflexion, significantly improved soleus muscle function and muscle blood flow during exercise in a rat model of aging . In a follow-up study, the investigators have also shown that this model improves vascular function and walking function in PAD patients. As noted above, muscle energetics are delayed in PAD patients, so improving the rest-to-exercise transition with creatine supplementation may help PAD patients sustain exercise longer. The investigators are now testing to see if an added supplement can further improve the effects of muscle stretching in PAD patients.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Peripheral Arterial Disease
Keywords
Muscle stretch, Creatine Monohydrate

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 2
Interventional Study Model
Parallel Assignment
Masking
Participant
Masking Description
Randomized, single-blind research design.
Allocation
Randomized
Enrollment
13 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Creatine monohydrate
Arm Type
Experimental
Arm Description
Creatine Monohydrate will be given at a 5 day loading period (10g/day) followed by a maintenance phase (5 g/day). The objectives of the current trial are to investigate if creatine supplementation plus muscle stretching improves 6-minute walking distance and muscle oxygenation in patients with peripheral artery disease.
Arm Title
Cellulose
Arm Type
Placebo Comparator
Arm Description
These participants will consume a fiber supplement in place of creatine monohydrate at a matched dose with muscle stretching.
Intervention Type
Drug
Intervention Name(s)
Creatine monohydrate
Intervention Description
Creatine monohydrate will be used in combination with muscle stretching.
Intervention Type
Dietary Supplement
Intervention Name(s)
Cellulose
Intervention Description
Cellulose will be used in combination with muscle stretching.
Primary Outcome Measure Information:
Title
Walking tolerance
Description
All patients will perform a pre -and -post 6 minute walking test to assess functional outcomes of muscle stretching and supplementation
Time Frame
4 weeks
Secondary Outcome Measure Information:
Title
Near infrared spectroscopy (NIRS)
Description
Use of NIRS on the lateral head of the gastrocnemius muscle in all patients will be performed. NIRS will be measured during a vascular occlusion test, during placement of splint device, and the 6 minute walking test.
Time Frame
4 weeks
Title
Magnetic Resonance Imaging (MRI)
Description
Use of MRI to assess muscle oxygenation during a vascular occlusion test at rest, and during placement of splint device
Time Frame
4 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
40 Years
Maximum Age & Unit of Time
95 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Ankle-brachial index (ABI) of 0.90 or less in either leg or clinical diagnosis by a medical doctor (PAD group only) Stable condition for at least 3 months (PAD group only) Exclusion Criteria: Habitual exercise or cardiovascular rehabilitation program during the past 3 months Critical limb ischemia Blow or above-knee amputation Leg pain at rest Major surgery or lower extremity revascularization in the last 3 months Major medical illness treatment during the prior 12 months Central neurological disease Limited ankle or knee joint range of motion Requirement of oxygen with activity or exercise Heart failure Atrial fibrillation Wheelchair confinement or inability to walk Cognitive disorder Vasculitis problems including Takayasu's arteritis, Berger's disease, collagen disease or Reynaud's disease Overt cardiovascular disease Metabolic disease Renal disease
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Judy Muller-Delp, Ph.D.
Organizational Affiliation
Professor
Official's Role
Principal Investigator
Facility Information:
Facility Name
Florida State University
City
Tallahassee
State/Province
Florida
ZIP/Postal Code
32304
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
8828669
Citation
Hultman E, Soderlund K, Timmons JA, Cederblad G, Greenhaff PL. Muscle creatine loading in men. J Appl Physiol (1985). 1996 Jul;81(1):232-7. doi: 10.1152/jappl.1996.81.1.232.
Results Reference
background
PubMed Identifier
29623692
Citation
Hotta K, Behnke BJ, Arjmandi B, Ghosh P, Chen B, Brooks R, Maraj JJ, Elam ML, Maher P, Kurien D, Churchill A, Sepulveda JL, Kabolowsky MB, Christou DD, Muller-Delp JM. Daily muscle stretching enhances blood flow, endothelial function, capillarity, vascular volume and connectivity in aged skeletal muscle. J Physiol. 2018 May 15;596(10):1903-1917. doi: 10.1113/JP275459. Epub 2018 Apr 5.
Results Reference
background

Learn more about this trial

Creatine Use and Muscle Stretching in Peripheral Artery Disease

We'll reach out to this number within 24 hrs